- Regeneron Pharmaceuticals (REGN, Financial) will participate in four key healthcare investor conferences in May and June 2025.
- Sessions will be webcast and accessible via the Regeneron investor relations website.
- Replays and transcripts will be available for at least 30 days post-events.
Regeneron Pharmaceuticals, Inc. (REGN), a leading biotechnology company, has announced its participation in four major healthcare investor conferences scheduled for May and June 2025. These conferences include the BofA Securities 2025 Health Care Conference on May 13, the RBC Capital Markets Global Healthcare Conference on May 20, the 41st Annual Strategic Decisions Conference by Bernstein on May 28, and the 46th Annual Global Healthcare Conference by Goldman Sachs on June 9.
All presentations by Regeneron will be available via webcast through the company's investor relations website at investor.regeneron.com/events-and-presentations. The company has ensured that replays and transcripts of these sessions will be accessible for at least 30 days following the events, allowing stakeholders ample time to review the content.
With a strong focus on transforming lives through scientific innovation, Regeneron continuously makes strides in developing treatments across various medical fields such as eye diseases, inflammatory diseases, cancer, and infectious diseases, among others. The company's participation in these conferences underscores its commitment to transparency and engagement with the investor community.
